Your browser doesn't support javascript.
loading
Cushing's syndrome.
Gadelha, Mônica; Gatto, Federico; Wildemberg, Luiz Eduardo; Fleseriu, Maria.
Affiliation
  • Gadelha M; Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Neuroendocrine Unit, Secretaria Estadual de Saúde, Rio de Janeiro, Brazil; Molecular Genetics Laboratory, Secretari
  • Gatto F; Endocrinology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Wildemberg LE; Neuroendocrine Unit, Secretaria Estadual de Saúde, Rio de Janeiro, Brazil.
  • Fleseriu M; Pituitary Center, Medicine and Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Lancet ; 402(10418): 2237-2252, 2023 12 09.
Article in En | MEDLINE | ID: mdl-37984386
Endogenous Cushing's syndrome results from excess glucocorticoid secretion, which leads to a myriad of clinical manifestations, comorbidities, and increased mortality despite treatment. Molecular mechanisms and genetic alterations associated with different causes of Cushing's syndrome have been described in the last decade. Imaging modalities and biochemical testing have evolved; however, both the diagnosis and management of Cushing's syndrome remain challenging. Surgery is the preferred treatment for all causes, but medical therapy has markedly advanced, with new drug options becoming available. Nevertheless, several comorbidities remain even after patient remission, which can affect quality of life. Accurate and timely diagnosis and treatment are essential for mitigating chronic complications of excess glucocorticoids and improving patient quality of life. In this Seminar, we aim to update several important aspects of diagnosis, complications, and treatment of endogenous Cushing's syndrome of all causes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cushing Syndrome Limits: Humans Language: En Journal: Lancet Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cushing Syndrome Limits: Humans Language: En Journal: Lancet Year: 2023 Type: Article